из той же статьи:
Two weeks after the second dose, the differences in vaccine effectiveness by variant were more modest, with the Pfizer/BioNTech jab offering 88% protection against symptomatic disease with the Delta variant, compared with 94% protection against the Alpha variant. For the Oxford/AstraZeneca vaccine, the figures were 67% and 74% respectively.